Manufacturer record
Adwin Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Adwin Pharma (Himachal Pradesh) were declared Not of Standard Quality between February 2022 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AYT070385, Esomeprazole Tablets IP (exp Jun 2027). DTL,Dalgate Srinagar kashmir (state lab) found it not of standard quality: The sample does not conform to IP 2022 requirements w.r.t Dissolution Test. Listed in the April 2026 alert.
Records by type
8 records linked to Adwin Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Esomeprazole Tablets IP | Batch AYT070385Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to IP 2022 requirements w.r.t Dissolution TestDissolution | DTL,Dalgate Srinagar kashmirState lab | Apr 2026 |
| Ansicef-20 DT (Cefixin Dispersiblelet Tablets IP mg) | Batch AJT-10016Mfg Jan 2024 · Exp Dec 2025 | The sample failed Assay (Label claim 32.5%) for cefixime & labelling as per IP (Spurious 32.5%)Assay | DCA Vijayawada, Andhara PradeshState lab | Jul 2025 |
| Cetquine 5 Tablets (Levocetirizine Dihydrochlorine Tablets IP | Batch ATX060546Mfg Jun 2023 · Exp May 2025 | The sample does not comply with IP requirements for Dissolution test.Dissolution | CDTL MumbaiCDSCO lab | Apr 2025 |
| Paroxetine Controlled Release Tablets (Proxy- CR 12.5) | Batch ATX070647Mfg Jul 2023 · Exp Jun 2025 | Assay and Related Substance of ParoxetineAssay | CDL KolkataCDSCO lab | Sep 2023 |
| Ambroxol HCl, Guaiphenesin, Terbutaline Sulphate & Menthol Syrup 100 ml (SKOOF) | Batch ALX07099Mfg Jul 2023 · Exp Jun 2025 | Assay of Ambroxol Hydrochlorid e & Terbutaline SulphateAssay | CDL KolkataCDSCO lab | Sep 2023 |
| Paracetamol Tablets IP | Batch ADT-08-0541Mfg Aug 2020 · Exp Jul 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2022 |
| Esomeprazole with Domperidone Tablets (ESSOF-D TABLETS) | Batch APT-10-1524Mfg Oct 2021 · Exp Sep 2023 | AssayAssay | RDTL ChandigarhState lab | Mar 2022 |
| Esomeprazole Tablets IP (ESSOF- 20 TABLETS) | Batch APT-07-0596Mfg Jul 2021 · Exp Jun 2023 | DissolutionDissolution | RDTL ChandigarhState lab | Feb 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.